Susquehanna International Group, LLP Cv Rx, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$7.15 - $12.37 $106,535 - $184,313	14,900 New	14,900 $131,000
Q1 2024 May 07, 2024	SELL	$17.99 - $30.49 $233,869 - $396,370	-13,000 Reduced 14.71%	75,400 $1.37 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $33.01 $367,605 - $1.04 Million	31,500 Added 55.36%	88,400 $2.78 Million
Q3 2023 Nov 14, 2023	BUY	$13.56 - $18.47 $513,924 - $700,013	37,900 Added 199.47%	56,900 $863,000
Q2 2023 Aug 11, 2023	SELL	$8.57 - $15.44 $87,414 - $157,488	-10,200 Reduced 34.93%	19,000 $293,000
Q1 2023 May 16, 2023	BUY	$7.08 - $19.4 $206,736 - $566,480	29,200 New	29,200 $272,000

14.4M

56.3K

41.8K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $286M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.